Topics
November/December 2012 | Retinal Imaging Feature
Investing in Technology for a Diagnostic Payoff
The CX-1 camera has helped improve patient workflow with high-quality imaging.
Neil F. Notaroberto, MD
May/June 2010 | Retinal Imaging Feature
Imaging and Pharmacologic Approaches in the Treatment of Geographic Atrophy in AMD
Imaging with FAF offers new insight into how and why GA progresses in some patients.
Frank G. Holz, MD
November 17, 2026
MacuMira Receives CE Mark Certification for Retinal Microcurrent Stimulation Device to Treat Dry AMD
November 16, 2026
Johnson & Johnson to Acquire Ollin Biosciences for $2.2 Billion, Advancing Retinal Disease Pipeline
RetinaLyze System Receives EU MDR Class 2a Certification for Retinal Screening Software
November 11, 2026
AAO, AOA Respond to FDA GLP-1 Drug Labeling Changes, Highlight NAION Risk and Eye Care Recommendations
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Supported by Zeiss
Free Print Subscription
Email Newsletter
Conference Calendar